2-((4-Chlorophenyl)(pyridin-2-yl)methoxy)-N,N-dimethylethanamine

CAS : 486-16-8

Ref. 3D-FC29955

Informations sur le produit

• Nom: 2-((4-Chlorophenyl)(pyridin-2-yl)methoxy)-N,N-dimethylethanamine
• Synonymes: Carbinoxamine, 2-(4-Chloro-Alpha-(2-Pyridyl)Benzyloxy)Ethyldimethylamine, 2-[(4-Chlorophenyl)-2-Pyridinylmethoxy]-N,N-Dimethylethanamine, 2-[P-Chloro-A-(2-Dimethylaminoethoxy)Benzyl]Pyridine, 2-[p-Chloro-α-[2-(dimethylamino)ethoxy]benzyl]pyridine, Carbinoxamin, Carbinoxamina, Carbinoxamine (base and/or unspecified salts), Ethanamine, 2-[(4-chlorophenyl)-2-pyridinylmethoxy]-N,N-dimethyl-, McN-R 73Z, Paracarbinoxamine, Paracarinoxamine, Pyridine, 2-[p-chloro-α-[2-(dimethylamino)ethoxy]benzyl]-, [2-[(4-Chlorophenyl)(pyridin-2-yl)methoxy]ethyl]dimethylamine

Description

2-((4-Chlorophenyl)(pyridin-2-yl)methoxy)-N,N-dimethylethanamine (ZDX) is a new nonsteroidal anti-inflammatory drug that has been developed for the treatment of allergic rhinitis and other allergy symptoms. ZDX blocks the action of the toll-like receptor 4 (TLR4), which is an important regulator in the inflammatory pathway. ZDX has shown a potent anti-inflammatory effect in vitro on human serum and in vivo on mice with carbinoxamine induced inflammation. It is a controlled release preparation that can be administered orally or through injection.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 290.79 g/mol
• Formule: C₁₆H₁₉N₂OCl
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C16H19ClN2O/c1-19(2)11-12-20-16(15-5-3-4-10-18-15)13-6-8-14(17)9-7-13/h3-10,16H,11-12H2,1-2H3
• Code InChI: InChIKey=OJFSXZCBGQGRNV-UHFFFAOYSA-N
• SMILES: CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1